Quick Answer
RAPID MICRO BIOSYSTEMS, INC. reported Net Income Loss of -$47.12 million for the year ending 2025.
- RAPID MICRO BIOSYSTEMS, INC. showed a decrease of -0.5% in Net Income Loss from 2024 to 2025.
- This data is from RAPID MICRO BIOSYSTEMS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$8.01 million | Q2 2020: -$9.27 million | Q3 2020: -$8.47 million | Q1 2021: -$22.10 million | Q2 2021: -$11.83 million | Q3 2021: -$24.99 million | Q1 2022: -$14.93 million | Q2 2022: -$13.09 million | Q3 2022: -$16.34 million | Q1 2023: -$13.89 million | Q2 2023: -$14.02 million | Q3 2023: -$13.39 million | Q1 2024: -$13.32 million | Q2 2024: -$12.58 million | Q3 2024: -$11.32 million | Q1 2025: -$11.26 million | Q2 2025: -$11.86 million | Q3 2025: -$11.51 million.
- Over the full 6 years of available data (2020 to 2025), RAPID MICRO BIOSYSTEMS, INC.'s Net Income Loss has declined by 27.1%.
- Historical annual values: Fiscal year 2025: -$47.12 million | Fiscal year 2024: -$46.89 million | Fiscal year 2023: -$52.47 million | Fiscal year 2022: -$60.81 million | Fiscal year 2021: -$73.52 million | Fiscal year 2020: -$37.08 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: